Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / House Bills / H.R. 10628

H.R. 10628

To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Print stageDateSize⠃
Introduced in House2026-09-2811.9K⠃⠗⠋